Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Xenetic Biosciences, Inc. - Common Stock
(NQ:
XBIO
)
3.040
-0.080 (-2.56%)
Streaming Delayed Price
Updated: 1:09 PM EDT, Mar 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xenetic Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
March 13, 2026
Via
ACCESS Newswire
Why Did UPB Stock Pop 20% In Pre-Market Today?
↗
February 11, 2026
The company announced positive top-line results from its Phase 2 VALIANT trial evaluating Verekitug in adults with severe asthma.
Via
Stocktwits
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
December 11, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
November 19, 2025
Via
Benzinga
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
November 19, 2025
Via
ACCESS Newswire
Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
November 13, 2025
Via
ACCESS Newswire
Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges
↗
October 10, 2025
Benzinga Edge Stock Rankings evaluate companies across four key factors. Here are three big companies that stood out this week.
Via
Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
October 10, 2025
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 10, 2025
Via
Benzinga
Which stocks are experiencing notable movement on Friday?
↗
October 10, 2025
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock
October 10, 2025
Via
ACCESS Newswire
4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings
↗
October 09, 2025
Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam as the market rally broadens and major indexes continue to reach new highs....
Via
Benzinga
Which stocks are moving before the opening bell on Thursday?
↗
October 09, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
↗
October 09, 2025
Via
Benzinga
MAGA Stocks Undercard: MYSE, XBIO, ATON, ACXP, RDZN – Innovators Driving Next Tech, Blockchain, AI Wave – More Stocks Inside
October 08, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Intellectual Property
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 08, 2025
Via
Benzinga
Nasdaq Gains 150 Points; US Mortgage Applications Decline
↗
October 08, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 08, 2025
Via
Benzinga
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
↗
October 08, 2025
Via
Benzinga
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results
August 13, 2025
Via
ACCESS Newswire
Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma
July 30, 2025
Via
ACCESS Newswire
Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
July 23, 2025
Via
ACCESS Newswire
Xenetic Biosciences, Inc. Announces Update from Collaboration Partner of First Patient Dosed in Exploratory Clinical Study of DNase I in Combination with FOLFIRINOX for the First Line Treatment of Unresectable, Locally Advanced or Metastatic Pancreatic
July 08, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 23, 2025
Via
Benzinga
Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
Via
ACCESS Newswire
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
April 09, 2025
Via
ACCESS Newswire
Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma
March 26, 2025
Via
ACCESS Newswire
Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results
March 19, 2025
Via
ACCESS Newswire
Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses
March 13, 2025
Via
ACCESS Newswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
